Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report08 June 2020
U-Battery has launched ‘Phase 2’ of the design and development of its micro nuclear reactor.
The launch, held last week by webinar due to the COVID-19 crisis, involved eight different supplier organisations, which will be playing key roles in the next stage.
Presentations were given on the U-Battery team, how the design has evolved and the next steps in realising its delivery, the potential markets, and roles and responsibilities for each organisation.
The productive two-hour event was concluded with a very engaged question and answer session.
Steve Threlfall, General Manager of U-Battery, said: “This kick-off meeting was an important opportunity to touch base again with our supply chain to ensure we have a common understanding of the objectives for the next phase.
“We were delighted with the attendance level and thoughtful comments and questions. There is a lot of momentum around the project and we are excited to be making positive progress in refining U-Battery’s design and development ready for the construction of a first of a kind reactor.”
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries